Have a feature idea you'd love to see implemented?
Let us know!
STTK Shattuck Labs Inc
Price (delayed)
$1.28
Market cap
$61.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.85
Enterprise value
$3.37M
Shattuck Labs, Inc. operates as a clinical-stage biotechnology company . The Company focuses on developing a novel class of biologic medicines for the treatment of cancer and autoimmune diseases. Shattuck
Highlights
STTK's revenue has surged by 52% since the previous quarter
Shattuck Labs's gross profit has surged by 52% QoQ
STTK's quick ratio is down by 22% YoY and by 12% QoQ
The company's equity fell by 20% YoY and by 14% QoQ
Key stats
What are the main financial stats of STTK
Market
Valuations
Earnings
Shares outstanding
47.73M
Market cap
$61.09M
Enterprise value
$3.37M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.55
Price to sales (P/S)
15.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.82
Revenue
$4.12M
EBIT
-$85.28M
EBITDA
-$80.95M
Free cash flow
-$63.28M
Per share
Balance sheet
Liquidity
EPS
-$1.85
Free cash flow per share
-$1.25
Book value per share
$2.33
Revenue per share
$0.08
TBVPS
$2.53
Total assets
$128.61M
Total liabilities
$18M
Debt
$2.97M
Equity
$110.62M
Working capital
$99.4M
Debt to equity
0.03
Current ratio
7.62
Quick ratio
7.01
Net debt/EBITDA
0.71
Margins
Efficiency
Dividend
EBITDA margin
-1,962.9%
Gross margin
100%
Net margin
-2,068%
Operating margin
-2,195.8%
Return on assets
-60.4%
Return on equity
-68.7%
Return on invested capital
-154.8%
Return on capital employed
-75.1%
Return on sales
-2,068%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STTK stock price
How has the Shattuck Labs stock price performed over time
Intraday
0%
1 week
-11.72%
1 month
-64.84%
1 year
-10.49%
YTD
-82.05%
QTD
-63.32%
Financial performance
How have Shattuck Labs's revenue and profit performed over time
Revenue
$4.12M
Gross profit
$4.12M
Operating income
-$90.56M
Net income
-$85.28M
Gross margin
100%
Net margin
-2,068%
The net margin has surged by 81% year-on-year and by 34% since the previous quarter
STTK's operating margin has surged by 80% year-on-year and by 34% since the previous quarter
STTK's revenue has surged by 52% since the previous quarter
Shattuck Labs's gross profit has surged by 52% QoQ
Growth
What is Shattuck Labs's growth rate over time
Valuation
What is Shattuck Labs stock price valuation
P/E
N/A
P/B
0.55
P/S
15.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.82
Shattuck Labs's EPS has increased by 15% YoY and by 4.1% from the previous quarter
The stock's price to book (P/B) is 71% less than its last 4 quarters average of 1.9
The company's equity fell by 20% YoY and by 14% QoQ
STTK's price to sales (P/S) is 86% lower than its last 4 quarters average of 111.5
STTK's revenue has surged by 52% since the previous quarter
Efficiency
How efficient is Shattuck Labs business performance
The ROIC has shrunk by 101% YoY and by 9% QoQ
Shattuck Labs's ROS has soared by 81% YoY and by 34% from the previous quarter
The ROE has declined by 25% year-on-year and by 6% since the previous quarter
STTK's return on assets is down by 25% year-on-year and by 5% since the previous quarter
Dividends
What is STTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STTK.
Financial health
How did Shattuck Labs financials performed over time
STTK's current ratio is down by 27% year-on-year and by 17% since the previous quarter
STTK's quick ratio is down by 22% YoY and by 12% QoQ
The debt is 97% smaller than the equity
The company's debt to equity has surged by 50% QoQ
The debt has declined by 22% year-on-year and by 7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.